866-997-4948(US-Canada Toll Free)

United States Bio-pharma Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 109 Pages

In this report, the United States Bio-pharma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Bio-pharma in these regions, from 2012 to 2022 (forecast).

United States Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bio-pharma for each application, including
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Bio-pharma Market Report 2017
1 Bio-pharma Overview
1.1 Product Overview and Scope of Bio-pharma
1.2 Classification of Bio-pharma by Product Category
1.2.1 United States Bio-pharma Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Bio-pharma Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Recombinant Proteins
1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.6 Interferons
1.2.7 Recombinant Human Insulin
1.2.8 Erythropoietin
1.2.9 Vaccines
1.2.10 Growth Hormones
1.2.11 Purified Proteins
1.2.12 Others
1.3 United States Bio-pharma Market by Application/End Users
1.3.1 United States Bio-pharma Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 United States Bio-pharma Market by Region
1.4.1 United States Bio-pharma Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Bio-pharma Status and Prospect (2012-2022)
1.4.3 Southwest Bio-pharma Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Bio-pharma Status and Prospect (2012-2022)
1.4.5 New England Bio-pharma Status and Prospect (2012-2022)
1.4.6 The South Bio-pharma Status and Prospect (2012-2022)
1.4.7 The Midwest Bio-pharma Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Bio-pharma (2012-2022)
1.5.1 United States Bio-pharma Sales and Growth Rate (2012-2022)
1.5.2 United States Bio-pharma Revenue and Growth Rate (2012-2022)

2 United States Bio-pharma Market Competition by Players/Suppliers
2.1 United States Bio-pharma Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Bio-pharma Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Bio-pharma Average Price by Players/Suppliers (2012-2017)
2.4 United States Bio-pharma Market Competitive Situation and Trends
2.4.1 United States Bio-pharma Market Concentration Rate
2.4.2 United States Bio-pharma Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Bio-pharma Manufacturing Base Distribution, Sales Area, Product Type

3 United States Bio-pharma Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Bio-pharma Sales and Market Share by Region (2012-2017)
3.2 United States Bio-pharma Revenue and Market Share by Region (2012-2017)
3.3 United States Bio-pharma Price by Region (2012-2017)

4 United States Bio-pharma Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Bio-pharma Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Bio-pharma Revenue and Market Share by Type (2012-2017)
4.3 United States Bio-pharma Price by Type (2012-2017)
4.4 United States Bio-pharma Sales Growth Rate by Type (2012-2017)

5 United States Bio-pharma Sales (Volume) by Application (2012-2017)
5.1 United States Bio-pharma Sales and Market Share by Application (2012-2017)
5.2 United States Bio-pharma Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Bio-pharma Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Bio-pharma Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
6.2.2 Bio-pharma Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson Services
6.3.2 Bio-pharma Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi, Amgen
6.4.2 Bio-pharma Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AbbVie
6.5.2 Bio-pharma Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck & Co., Inc
6.6.2 Bio-pharma Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biogen Idec
6.7.2 Bio-pharma Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer AG
6.8.2 Bio-pharma Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
6.9.2 Bio-pharma Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG GlaxoSmithKline Plc
6.10.2 Bio-pharma Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb Company
6.12 AstraZeneca PLC
6.13 Abbott Laboratories

7 Bio-pharma Manufacturing Cost Analysis
7.1 Bio-pharma Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bio-pharma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Bio-pharma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Bio-pharma Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Bio-pharma Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Bio-pharma Sales Volume Forecast by Type (2017-2022)
11.3 United States Bio-pharma Sales Volume Forecast by Application (2017-2022)
11.4 United States Bio-pharma Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Bio-pharma
Figure United States Bio-pharma Market Size (K Pcs) by Type (2012-2022)
Figure United States Bio-pharma Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Figure United States Bio-pharma Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Bio-pharma Market Size (Million USD) by Region (2012-2022)
Figure The West Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-pharma Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-pharma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Bio-pharma Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Bio-pharma Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-pharma Sales Share by Players/Suppliers
Figure 2017 United States Bio-pharma Sales Share by Players/Suppliers
Figure United States Bio-pharma Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Bio-pharma Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Bio-pharma Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-pharma Revenue Share by Players/Suppliers
Figure 2017 United States Bio-pharma Revenue Share by Players/Suppliers
Table United States Market Bio-pharma Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Bio-pharma Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Bio-pharma Market Share of Top 3 Players/Suppliers
Figure United States Bio-pharma Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Bio-pharma Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Bio-pharma Product Category
Table United States Bio-pharma Sales (K Pcs) by Region (2012-2017)
Table United States Bio-pharma Sales Share by Region (2012-2017)
Figure United States Bio-pharma Sales Share by Region (2012-2017)
Figure United States Bio-pharma Sales Market Share by Region in 2016
Table United States Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Bio-pharma Revenue Share by Region (2012-2017)
Figure United States Bio-pharma Revenue Market Share by Region (2012-2017)
Figure United States Bio-pharma Revenue Market Share by Region in 2016
Table United States Bio-pharma Price (USD/Pcs) by Region (2012-2017)
Table United States Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table United States Bio-pharma Sales Share by Type (2012-2017)
Figure United States Bio-pharma Sales Share by Type (2012-2017)
Figure United States Bio-pharma Sales Market Share by Type in 2016
Table United States Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Bio-pharma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type in 2016
Table United States Bio-pharma Price (USD/Pcs) by Types (2012-2017)
Figure United States Bio-pharma Sales Growth Rate by Type (2012-2017)
Table United States Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table United States Bio-pharma Sales Market Share by Application (2012-2017)
Figure United States Bio-pharma Sales Market Share by Application (2012-2017)
Figure United States Bio-pharma Sales Market Share by Application in 2016
Table United States Bio-pharma Sales Growth Rate by Application (2012-2017)
Figure United States Bio-pharma Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Bio-pharma Sales Growth Rate (2012-2017)
Figure Pfizer Bio-pharma Sales Market Share in United States (2012-2017)
Figure Pfizer Bio-pharma Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Services Basic Information List
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share in United States (2012-2017)
Table Sanofi, Amgen Basic Information List
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Growth Rate (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Market Share in United States (2012-2017)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Bio-pharma Sales Growth Rate (2012-2017)
Figure AbbVie Bio-pharma Sales Market Share in United States (2012-2017)
Figure AbbVie Bio-pharma Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share in United States (2012-2017)
Table Biogen Idec Basic Information List
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Bio-pharma Sales Growth Rate (2012-2017)
Figure Biogen Idec Bio-pharma Sales Market Share in United States (2012-2017)
Figure Biogen Idec Bio-pharma Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Bio-pharma Sales Growth Rate (2012-2017)
Figure Bayer AG Bio-pharma Sales Market Share in United States (2012-2017)
Figure Bayer AG Bio-pharma Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share in United States (2012-2017)
Table Novartis AG GlaxoSmithKline Plc Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Growth Rate (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Market Share in United States (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table AstraZeneca PLC Basic Information List
Table Abbott Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Players/Suppliers in 2016
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure United States Bio-pharma Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Bio-pharma Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Bio-pharma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-pharma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-pharma Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *